Status: Recruiting
Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection
In this Dutch multicenter clinical trial, patients with a staphylococcal prosthetic joint infection, will, in the oral antibiotic treatment phase, be randomized between clindamycin monotherapy and rifampicin / levofloxacin combination therapy. The clinical endpoint will be treatment success one year after finishing antimicrobial treatment.
Participants needed: 316
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Leiden University Medical CenterUpdated: Dec 15, 2023Locations: 13
Eligibility criteria
>18 years of age [+3]